News & Events

Date	Title	Format
Mar 27, 2023	Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases	PDF Version
Mar 22, 2023	Cyclerion Reports Corporate Update and Full Year 2022 Financial Results	PDF Version

Print Page Email Alerts RSS Feeds

Top